281 related articles for article (PubMed ID: 24951958)
1. β3 adrenergic receptor selective stimulation during ischemia/reperfusion improves cardiac function in translational models through inhibition of mPTP opening in cardiomyocytes.
García-Prieto J; García-Ruiz JM; Sanz-Rosa D; Pun A; García-Alvarez A; Davidson SM; Fernández-Friera L; Nuno-Ayala M; Fernández-Jiménez R; Bernal JA; Izquierdo-Garcia JL; Jimenez-Borreguero J; Pizarro G; Ruiz-Cabello J; Macaya C; Fuster V; Yellon DM; Ibanez B
Basic Res Cardiol; 2014 Jul; 109(4):422. PubMed ID: 24951958
[TBL] [Abstract][Full Text] [Related]
2. Cardioprotective Effects of Beta3-Adrenergic Receptor (β3-AR) Pre-, Per-, and Post-treatment in Ischemia-Reperfusion.
Salie R; Alsalhin AKH; Marais E; Lochner A
Cardiovasc Drugs Ther; 2019 Apr; 33(2):163-177. PubMed ID: 30729348
[TBL] [Abstract][Full Text] [Related]
3. Matrix metalloproteinase inhibition protects CyPD knockout mice independently of RISK/mPTP signalling: a parallel pathway to protection.
Bell RM; Kunuthur SP; Hendry C; Bruce-Hickman D; Davidson S; Yellon DM
Basic Res Cardiol; 2013 Mar; 108(2):331. PubMed ID: 23361433
[TBL] [Abstract][Full Text] [Related]
4. Irisin plays a pivotal role to protect the heart against ischemia and reperfusion injury.
Wang H; Zhao YT; Zhang S; Dubielecka PM; Du J; Yano N; Chin YE; Zhuang S; Qin G; Zhao TC
J Cell Physiol; 2017 Dec; 232(12):3775-3785. PubMed ID: 28181692
[TBL] [Abstract][Full Text] [Related]
5. Rosuvastatin postconditioning protects isolated hearts against ischemia-reperfusion injury: The role of radical oxygen species, PI3K-Akt-GSK-3β pathway, and mitochondrial permeability transition pore.
Liu CW; Yang F; Cheng SZ; Liu Y; Wan LH; Cong HL
Cardiovasc Ther; 2017 Feb; 35(1):3-9. PubMed ID: 27580017
[TBL] [Abstract][Full Text] [Related]
6. Mitochondrial cyclophilin-D as a critical mediator of ischaemic preconditioning.
Hausenloy DJ; Lim SY; Ong SG; Davidson SM; Yellon DM
Cardiovasc Res; 2010 Oct; 88(1):67-74. PubMed ID: 20400621
[TBL] [Abstract][Full Text] [Related]
7. Direct evidence for inhibition of mitochondrial permeability transition pore opening by sevoflurane preconditioning in cardiomyocytes: comparison with cyclosporine A.
Onishi A; Miyamae M; Kaneda K; Kotani J; Figueredo VM
Eur J Pharmacol; 2012 Jan; 675(1-3):40-6. PubMed ID: 22166375
[TBL] [Abstract][Full Text] [Related]
8. MicroRNA-21 Mediates Isoflurane-induced Cardioprotection against Ischemia-Reperfusion Injury via Akt/Nitric Oxide Synthase/Mitochondrial Permeability Transition Pore Pathway.
Qiao S; Olson JM; Paterson M; Yan Y; Zaja I; Liu Y; Riess ML; Kersten JR; Liang M; Warltier DC; Bosnjak ZJ; Ge ZD
Anesthesiology; 2015 Oct; 123(4):786-798. PubMed ID: 26259139
[TBL] [Abstract][Full Text] [Related]
9. Mirabegron, a Clinically Approved β3 Adrenergic Receptor Agonist, Does Not Reduce Infarct Size in a Swine Model of Reperfused Myocardial Infarction.
Rossello X; Piñero A; Fernández-Jiménez R; Sánchez-González J; Pizarro G; Galán-Arriola C; Lobo-Gonzalez M; Vilchez JP; García-Prieto J; García-Ruiz JM; García-Álvarez A; Sanz-Rosa D; Ibanez B
J Cardiovasc Transl Res; 2018 Aug; 11(4):310-318. PubMed ID: 30073540
[TBL] [Abstract][Full Text] [Related]
10. Tongmai formula improves cardiac function via regulating mitochondrial quality control in the myocardium with ischemia/reperfusion injury.
Zhao Y; Guo R; Li L; Li S; Fan G; Zhao X; Wang Y
Biomed Pharmacother; 2020 Dec; 132():110897. PubMed ID: 33113431
[TBL] [Abstract][Full Text] [Related]
11. Cardioprotection by post-conditioning with exogenous triiodothyronine in isolated perfused rat hearts and isolated adult rat cardiomyocytes.
Lieder HR; Braczko F; Gedik N; Stroetges M; Heusch G; Kleinbongard P
Basic Res Cardiol; 2021 Apr; 116(1):27. PubMed ID: 33876304
[TBL] [Abstract][Full Text] [Related]
12. B7-33, a Functionally Selective Relaxin Receptor 1 Agonist, Attenuates Myocardial Infarction-Related Adverse Cardiac Remodeling in Mice.
Devarakonda T; Mauro AG; Guzman G; Hovsepian S; Cain C; Das A; Praveen P; Hossain MA; Salloum FN
J Am Heart Assoc; 2020 Apr; 9(8):e015748. PubMed ID: 32295457
[TBL] [Abstract][Full Text] [Related]
13. Urocortin prevents mitochondrial permeability transition in response to reperfusion injury indirectly by reducing oxidative stress.
Townsend PA; Davidson SM; Clarke SJ; Khaliulin I; Carroll CJ; Scarabelli TM; Knight RA; Stephanou A; Latchman DS; Halestrap AP
Am J Physiol Heart Circ Physiol; 2007 Aug; 293(2):H928-38. PubMed ID: 17483234
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of Mas G-protein signaling improves coronary blood flow, reduces myocardial infarct size, and provides long-term cardioprotection.
Zhang T; Li Z; Dang H; Chen R; Liaw C; Tran TA; Boatman PD; Connolly DT; Adams JW
Am J Physiol Heart Circ Physiol; 2012 Jan; 302(1):H299-311. PubMed ID: 22003054
[TBL] [Abstract][Full Text] [Related]
15. Melatonin protects against heart ischemia-reperfusion injury by inhibiting mitochondrial permeability transition pore opening.
Petrosillo G; Colantuono G; Moro N; Ruggiero FM; Tiravanti E; Di Venosa N; Fiore T; Paradies G
Am J Physiol Heart Circ Physiol; 2009 Oct; 297(4):H1487-93. PubMed ID: 19684190
[TBL] [Abstract][Full Text] [Related]
16. Preconditioning or Postconditioning with 8-Br-cAMP-AM Protects the Heart against Regional Ischemia and Reperfusion: A Role for Mitochondrial Permeability Transition.
Khaliulin I; Ascione R; Maslov LN; Amal H; Suleiman MS
Cells; 2021 May; 10(5):. PubMed ID: 34067674
[TBL] [Abstract][Full Text] [Related]
17. Apelin-13 and apelin-36 exhibit direct cardioprotective activity against ischemia-reperfusion injury.
Simpkin JC; Yellon DM; Davidson SM; Lim SY; Wynne AM; Smith CC
Basic Res Cardiol; 2007 Nov; 102(6):518-28. PubMed ID: 17694254
[TBL] [Abstract][Full Text] [Related]
18. The Melatonin Receptor Agonist Ramelteon Induces Cardioprotection that Requires MT2 Receptor Activation and Release of Reactive Oxygen Species.
Stroethoff M; Goetze L; Torregroza C; Bunte S; Raupach A; Heinen A; Mathes A; Hollmann MW; Huhn R
Cardiovasc Drugs Ther; 2020 Jun; 34(3):303-310. PubMed ID: 32236860
[TBL] [Abstract][Full Text] [Related]
19. BLT1 antagonist LSN2792613 reduces infarct size in a mouse model of myocardial ischaemia-reperfusion injury.
de Hoog VC; Bovens SM; de Jager SC; van Middelaar BJ; van Duijvenvoorde A; Doevendans PA; Pasterkamp G; de Kleijn DP; Timmers L
Cardiovasc Res; 2015 Dec; 108(3):367-76. PubMed ID: 26449403
[TBL] [Abstract][Full Text] [Related]
20. Protective effects of sphingosine-1-phosphate receptor agonist treatment after myocardial ischaemia-reperfusion.
Hofmann U; Burkard N; Vogt C; Thoma A; Frantz S; Ertl G; Ritter O; Bonz A
Cardiovasc Res; 2009 Jul; 83(2):285-93. PubMed ID: 19416991
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]